ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 638

Are There Clinical Demographic or Subclinical Ultrasonographic Data That Can Predict Flare in Psoriatic Arthritis Patients during a Phase of Minimal Disease Activity after Spacing of Anti-TNF Blockers Injections?

Pierluigi Macchioni1, Giovanni Ciancio2, Gilda Sandri3, Alen Zabotti4, Luca Montaguti5, Gentiana Vukatana6, Fabio Mascella7, Donatella Chessa8, Elisa Verduci9, Marcello Govoni10, Amelia Spinella3, Francesca Zuliani11, Marco Bruschi5, Nazzarena Malavolta12 and Mariacristina Focherini7, 1Rheumatology Unit, Arcispedale S Maria Nuova, IRCCS, Reggio Emilia, Italy, 2Rheumatology Unit, Department of Medical Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria Sant’Anna - Ferrara (Italy), ferrara, Italy, 3Rheumatology Unit, University fo Modena & Reggio, Modena, Italy, 4Rheumatology Clinic, Department of Medical and Biological Sciences, Santa Maria della Misericordia" University Hospital, Udine, Italy, 5Dipartimento Internistico SS di Reumatologia, AUSL Romagna Ospedale Bufalini, Cesena, Italy, 6Rheumatology Unit, Department CardioThoracic Vascular, S.Orsola- Malpighi Hospital, Alma Mater Studiorum, Bologna, Bologna, Italy, 7Internal Medicine and Rheumatology, Ospedale Infermi Rimini, Rimini, Italy, 8Internal Medicine, Ospedale Paolo Dettori, Tempio Pausania, Italy, 9Rheumatology Unit, Arcispedale S. Maria Nuova, Reggio Emilia, Italy, 10Rheumatology Clinic, Department of Medical and Biological Sciences, University of Ferrara and Azienda Ospedaliera-Universitaria Sant’Anna - Ferrara (Italy), ferrara, Italy, 11Rheumatology Unit, Department of Medical Sciences, Santa Maria della Misericordia" University Hospital, Udine, Italy, 12Policlinico S.Orsola-Malpighi, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: anti-TNF therapy, Psoriatic arthritis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Tumour necrosis factor (TNF)-blocker tapering has been proposed for patients with psoriatic arthritis (PA) in clinical remission. To evaluate if there are clinical, demographic and ultrasound (US) data predictive of disease recurrence after spacing of anti-TNF therapy in PA patient during a phase of minimal disease activity (MDA)

Methods:

Patients treated with anti-TNF for at least 12 months and with at least 6 months duration of MDA were consecutively recruited at 6 Italian centers.

In every center, the local rheumatologists provided PA pts to be examined by US. Personal history, demographic and clinical data were recorded. Each patient underwent the following US examinations : metacarpophalangeal (MCP), knee and tibio-tarsal (TT) joint, flexor and extensor tendon of hand digit, flexor and extensor tendon at carpal area, flexor and extensor tendon of foot, and enthesis of common extensor tendon insertion on the lateral epicondyle of the humerus, quadriceps tendon, patellar tendon, Achilles tendon and plantar fascia insertions on the calcaneus.. Each examination were performed by rheumatologists expert in US, to assess synovitis (joint effusion, synovial proliferation, and power Doppler (PD) signal), and bone erosions, flexor tendon tensynovitis, ext tendon tenonitis, and enthesel involvement using an Esaote MyLabClass with a 5-13 or 6-18 MHz linear probe. US examinators were blind of clinical data of the pts. After the clinical and US examination patients increased the interval between the anti-TNF administration according to a common protocol. The patients were clinically evaluated at three month interval for the maintenance of a state of MDA. Baseline clinical and US data were compared between the group of patients still in MDA at the end of a minimum follow-up period of 6 month vs the group of patient with disease recurrence.

Results:

Sixty-three pts were recruited (mean age 53+13y, mean PA duration 13+8y, mean. MDA duration 21+11m). At the end of follow-up period 5 patient were lost, 47 (81%) maintained a state of MDA and 11 (19%) had recurrence. At baseline US examination 66.7 % of pts had at least one peripheral joint involved (17.5 % had peripheral active synovitis), 47.6% had acute enthesitis and 95.2% chronic enthesopathy. US bursitis was present in 22.2% of pts, 3.7% had hand extensor finger tendon involvement. No significant difference in any US and demographic data were present between the group in persistent MDA vs the recurred group. Patients with baseline Maastricht enthesis index (MEI) > 0 had higher risk of recurrences as compared with the group with MEI = 0 (36% vs 10%, p = 0.034).

Conclusion:

The presence of joint, entheseal and tendon abnormalities at US examination are not predictive of disease recurrence after anti-TNF spacing in PA patients in MDA. Only a value of MEI > 0 is significanly correlated to recurrence.

/span>


Disclosure: P. Macchioni, None; G. Ciancio, None; G. Sandri, None; A. Zabotti, None; L. Montaguti, None; G. Vukatana, None; F. Mascella, None; D. Chessa, None; E. Verduci, None; M. Govoni, None; A. Spinella, None; F. Zuliani, None; M. Bruschi, None; N. Malavolta, None; M. Focherini, None.

To cite this abstract in AMA style:

Macchioni P, Ciancio G, Sandri G, Zabotti A, Montaguti L, Vukatana G, Mascella F, Chessa D, Verduci E, Govoni M, Spinella A, Zuliani F, Bruschi M, Malavolta N, Focherini M. Are There Clinical Demographic or Subclinical Ultrasonographic Data That Can Predict Flare in Psoriatic Arthritis Patients during a Phase of Minimal Disease Activity after Spacing of Anti-TNF Blockers Injections? [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/are-there-clinical-demographic-or-subclinical-ultrasonographic-data-that-can-predict-flare-in-psoriatic-arthritis-patients-during-a-phase-of-minimal-disease-activity-after-spacing-of-anti-tnf-blockers/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/are-there-clinical-demographic-or-subclinical-ultrasonographic-data-that-can-predict-flare-in-psoriatic-arthritis-patients-during-a-phase-of-minimal-disease-activity-after-spacing-of-anti-tnf-blockers/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology